Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / October 13, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM). Investors who purchased Outset securities are encouraged to obtain additional informati...
2023-10-13 08:27:23 ET More on Momentus, Phio Pharmaceuticals, etc. Momentus Inc. (MNTS) Q2 2023 Earnings Call Transcript Wheeler REIT: Gearing Up For Sharemageddon Momentus to provide orbital delivery services for RIDE! Space Momentus prices $5M stock offeri...
2023-10-13 08:18:36 ET More on Outset Medical Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade) Outset Medical slumps after slashing 2023 revenue outlook For further details see: Outset tumbles ~40% after Bofa downgrades following gui...
2023-10-13 06:19:04 ET Outset Medical, Inc. (OM) Q3 2023 Earnings Conference Call October 12, 2023, 04:30 PM ET Company Participants Jim Mazzola - VP, IR Leslie Trigg - Chair & CEO Nabeel Ahmed - CFO Conference Call Participants Suraj Kalia - Oppe...
2023-10-13 05:27:15 ET Related stories Comtech Telecommunications Corp. (CMTL) Q4 2023 Earnings Call Transcript Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade) Dollar General: A Strong Earnings Compounder Facing Growth Ceiling F...
2023-10-12 16:26:48 ET More on Outset Medical Dialysis stocks decline again as Novo Nordisk hits 52-week high Dialysis stocks tumble on Ozempic kidney failure study news (update) For further details see: Outset Medical expects higher 2023 revenue year on year
Conference Call Scheduled for 4:30 p.m. ET Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), today announced preliminary financial results for the third quarter ended Sept. 30, 2023, and provided updated financial guidance for 2023. Prelimi...
2023-10-12 13:24:12 ET More on Baxter, DaVita, etc. Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial? Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade) DaVita: Continued Economic Hurdles, Market Expectations May Be...
MONTREAL, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the " Company " or " Osisko Metals ") ( TSX-V: OM ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased to announce additional assay results from its 2023 drilling program at the Pine Point Project, lo...
2023-10-11 16:06:03 ET More on Baxter Dividend Challengers Review: Baxter International Baxter International Inc. (BAX) Q2 2023 Earnings Call Transcript Dialysis stocks tumble in wake of Ozempic kidney failure study update Baxter appoints Joel Grade CFO ...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...